Thursday, December 18, 2025 12/18/2025

Rates of brain acetylome remodeling in a mouse model of diabetes and tauopathy

Award Number: R21AG085590
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/30/2023
PERIOD OF PERFORMANCE END DATE: 09/29/2026

Group Awards By:

View Award Description

Rates of brain acetylome remodeling in a mouse model of diabetes and tauopathy - Alzheimer's disease (AD) is one of the top ten causes of death in the United States, and there is no cure. AD is characterized by tauopathy, the accumulation of hyperphosphorylated microtubule- associated protein tau (MAPT, tau), and is linked to metabolic dysregulation. Type 2 diabetes mellitus (T2DM) is a risk factor for late-onset AD, but the mechanistic link between the two is unclear. Post-translational protein lysine N(epsilon) acetylation by the central metabolite acetyl-CoA has been identified as an essential regulatory mechanism in intermediary metabolism, epigenetics, and protein stability. T2DM is characterized by altered substrate metabolism, which impacts acetylation and deacetylation co-factors NAD+ and acetyl-CoA. Dysregulated histone and tau acetylation have been linked with age-dependent memory impairment. In vitro studies suggest that acetylation contributes to tau aggregation. The in vivo impact of site-specific acetylation on brain protein, including tau turnover, is unknown. To investigate this, we developed a 2H2O (stable isotope)-based mass spectrometry method to quantify protein turnover and assess the effect of post-translational modifications (PTMs) on protein stability in vivo. The study aims to evaluate the role of acetylation on brain proteome dynamics in the htau mouse model of AD. The first aim quantifies proteome and acetylome dynamics in the hippocampus and frontal cortex of diet-induced diabetic and non-diabetic AD mice to determine the effect of T2DM-related dysregulated acetylation on brain protein stability in vivo. The second aim assesses the role of T2DM on the acetylation turnover of brain proteins in vivo. The research team will also determine how T2DM-related altered acetylation contributes to tauopathy and cognitive decline in AD. These experiments will establish the feasibility of the acetylome dynamics method and motivate the development of new AD therapies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2023	NORTHEAST OHIO MEDICAL UNIVERSITY	4209 STATE ROUTE 44	ROOTSTOWN	OH	44272	PORTAGE	USA	Aging Research	000	1	12/10/2025	NEW	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $429,000 )
2023	2023	NORTHEAST OHIO MEDICAL UNIVERSITY	4209 STATE ROUTE 44	ROOTSTOWN	OH	44272	PORTAGE	USA	Aging Research	000	1	9/20/2023	NEW	$429,000
														Subtotal = $429,000

Grand Total All Awards = $429,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Rates of brain acetylome remodeling in a mouse model of diabetes and tauopathy

Award Number: R21AG085590

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/30/2023

PERIOD OF PERFORMANCE END DATE: 09/29/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer